转换抑制
交易激励
转录因子
糖皮质激素受体
免疫抑制
心理压抑
核受体
生物
糖皮质激素
转录活性
受体
癌症研究
免疫学
细胞生物学
遗传学
基因
基因表达
作者
Bart van der Burg,Johan Lidén,Sam Okret,Franck Delaunay,Sacha Wissink,Paul T. van der Saag,Jan-Ακε Gustafsson
标识
DOI:10.1016/s1043-2760(97)00006-4
摘要
The transcription factor nuclear factor-kappaB (NF-kappaB) directs transcription of a large number of key molecules in immunological and inflammatory responses. The recently discovered inhibition of transcriptional activity of this factor by the activated glucocorticoid receptor (GR) provides a molecular basis for the potent antiinflammatory and immunosuppressive properties of glucocorticoids. This repressive activity of the GR can function independently of transcriptional activity. Because it has been shown that certain steroid receptor ligands can differentially address transactivation and transrepression functions, it may be possible to develop ligands that specifically suppress NF-kappaB activity and, as a result, are more efficient in treatment of a variety of important chronic inflammatory diseases with less severe side effects than those of currently available drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI